cariboubio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Caribou Biosciences | Developing Sophisticated Allogeneic Cell |
| Description | Precision Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 69.63.140.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cariboubio.com Valuation
|
US$42,972,867
Last updated: 2023-05-08 00:22:46
cariboubio.com has Semrush global rank of 246,302. cariboubio.com has an estimated worth of US$ 42,972,867, based on its estimated Ads revenue. cariboubio.com receives approximately 4,958,408 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, cariboubio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$42,972,867 |
| Daily Ads Revenue | US$39,668 |
| Monthly Ads Revenue | US$1,190,018 |
| Yearly Ads Revenue | US$14,280,215 |
| Daily Unique Visitors | 330,561 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cariboubio.com. | A | 299 | IP: 69.63.140.80 |
| cariboubio.com. | NS | 86400 | NS Record: ns-1524.awsdns-62.org. |
| cariboubio.com. | NS | 86400 | NS Record: ns-2019.awsdns-60.co.uk. |
| cariboubio.com. | NS | 86400 | NS Record: ns-245.awsdns-30.com. |
| cariboubio.com. | NS | 86400 | NS Record: ns-835.awsdns-40.net. |
| cariboubio.com. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
| cariboubio.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
| cariboubio.com. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
| cariboubio.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| cariboubio.com. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com ~all |
| cariboubio.com. | TXT | 300 | TXT Record: apple-domain-verification=Bzhi3spesAlAs2QH |
HtmlToTextCheckTime:2023-05-08 00:22:46
| We are a clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases. Precision Our proprietary chRDNA (CRISPR hybrid RNA-DNA) technology enables improved genome-editing specificity at high efficiency, and we are applying chRDNA to develop sophisticated genome-edited cell therapies. Allogeneic Building upon the early successes of autologous cell therapies, we are developing next-generation allogeneic CAR-T and CAR-NK cell therapies with significant potential to address the limitations of patient-derived treatments. Persistence We believe persistence is the key to developing successful allogeneic cell therapies. We use our proprietary technologies to enhance persistence by preventing rejection or rapid exhaustion of donor-derived cell therapies. “Caribou is a leader in the CRISPR field, successfully leveraging its proprietary genome-editing technology to develop allogeneic cell therapies that are |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Fri, 29 Oct 2021 00:50:54 GMT Server: Apache Location: https://www.cariboubio.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 00:50:55 GMT Server: Apache Vary: User-Agent,Accept-Encoding Last-Modified: Thu, 14 Oct 2021 04:10:01 GMT Cache-Control: max-age=30, s-maxage=30 Expires: Fri, 29 Oct 2021 00:51:25 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Content-Security-Policy-Report-Only: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self'; frame-src 'self' player.vimeo.com *.youtube.com www.google.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com www.googletagmanager.com maps.googleapis.com; img-src 'self' data: www.google-analytics.com maps.googleapis.com maps.gstatic.com www.googletagmanager.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
cariboubio.com Whois Information
Domain Name: CARIBOUBIO.COM Registry Domain ID: 1690916256_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.registrar.amazon.com Registrar URL: http://registrar.amazon.com Updated Date: 2020-11-02T23:37:48Z Creation Date: 2011-12-07T17:45:36Z Registry Expiry Date: 2021-12-07T17:45:36Z Registrar: Amazon Registrar, Inc. Registrar IANA ID: 468 Registrar Abuse Contact Email: abuse@amazonaws.com Registrar Abuse Contact Phone: +1.2067406200 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1524.AWSDNS-62.ORG Name Server: NS-2019.AWSDNS-60.CO.UK Name Server: NS-245.AWSDNS-30.COM Name Server: NS-835.AWSDNS-40.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T15:40:12Z <<< |